The platform for open scholarly exchange and collaboration.

Home » ncRNA-Cancer

2nd International Symposium on Frontiers in Molecular Science
Non-Coding RNAs and Epigenetics in Cancer

Non-Coding RNAs and Epigenetics in Cancer

21–23 June 2017

Biocenter, University of Basel, Basel, Switzerland

An international scientific conference organized by the MDPI journals International Journal of Molecular Sciences and Non-Coding RNA

International Journal of Molecular Sciences (ISSN 1422-0067; CODEN: IJMCFK; ISSN 1661-6596 for printed edition) is an open access journal providing an advanced forum for biochemistry, molecular biology and molecular pathology, and is published monthly online by MDPI. Impact Factor: 3.257 (2015) ; 5-Year Impact Factor: 3.213 (2015)

Welcome

One of the most unexpected and fascinating discoveries in oncology over the past decade has been the interplay between abnormalities in protein-coding genes and non-coding RNAs (ncRNAs), which are causally involved in cancer initiation, progression, and dissemination. Although, to date, the most studied non-coding RNAs (ncRNAs) are miRNAs, the importance of long non-coding RNAs (lncRNAs) is increasingly being recognized. At the conference, entitled “Non-Coding RNAs and Epigenetics in Cancer”, leaders in the field will present the roles of miRNAs and lncRNAs in cancer, with a focus on the recently identified novel mechanisms of action, and discuss the current strategies in designing ncRNA-targeting therapeutics, as well as the associated challenges. We hope to see you all, young in spirit and mind, in the new Eldorado of Science topics in biomedical sciences!

The Non-Coding RNAs and Epigenetics in Cancer will be held in Basel, Switzerland, from 21st to 23rd of June 2017. It will comprise five plenary sessions to highlight the most exciting developments and the latest breakthroughs in oncology. 

If you are interested in participating in this conference, and in presenting a poster, or in being selected for a short talk, please register and get in touch with the conference secretariat. The program of the conference is being assembled and will be fully available by the end of 2016. 

Chairman

 

Prof. George A. CalinGEORGE CALIN
The University of Texas MD Anderson Cancer Center, Houston, TX, USA      

 

 

  

Scientific Committee

 

Prof. John S. MattickJOHN MATTICK
Institute Director and Head, RNA Biology and Plasticity Laboratory
Senior Principal Research Fellow, Garvan Institute of Medical Research
University of New South Wales, Sydney, Australia 

 

  

Prof. Manel EstellerMANEL ESTELLER
Leader of the Cancer Epigenetics Group 
Bellvitge Biomedical Research Institute (IDIBELL)
Barcelona, Spain

 

  

Dr. Massimo NegriniMASSIMO NEGRINI
Department of Morphology
Surgery and Experimental Medicine
University of Ferrara, Italy

 

    

Prof. Thomas SchmittgenTHOMAS SCHMITTGEN
College of Pharmacy, University of Florida, Gainesville, USA

 

 

 

Prof. Frank J. SlackFRANK SLACK
Professor, Pathology, Harvard Medical School
Professor, Pathology, Beth Israel Deaconess Medical Center,
Boston, USA            

 

 

 

Confirmed Main Speakers

 

Prof. Reuven AgamiReuven
Netherlands Cancer Institute - NKI
Amsterdam, The Netherlands

 

 

 

Prof. Carlo Crocecarlo
Department of Cancer Biology and Genetics
The Ohio State University, USA

 

 

Prof. Manuela Ferracinmanuela
Department of Specialised, Experimental, and Diagnostic Medicine
University of Bologna, Italy

 

  

Prof. Fabbri Mullerfabbri
Pediatrics and Molecular Microbiology and Immunology
Children's Hospital Los Angeles
University of Southern California, USA

 

 

Dr. Maite Huarte Martinezmaite
Center for Applied Medical Research (CIMA)
University of Navarra, Spain

 

 

 

Prof. Ulf Andersson Oromulf
Long non-coding RNA Research Group
Max Planck Institute for Molecular Genetics, Germany

 

 

  

Prof. Amy Pasquinelliamy
Division of Biological Sciences
University of California, USA

 

 

Prof. Kalpana Ghoshal
KalpanaDepartment of Pathology
The Ohio State University, USA

 

 

 

Prof. Sven Diederichs
Division Head RNA Biology & Cancer 
DKFZ - Deutsches Krebsforschungszentrum, Germany 

 

 

Prof. Thomas SchmittgenTHOMAS SCHMITTGEN
College of Pharmacy, University of Florida, Gainesville, USA

 


  

Prof. Manel EstellerMANEL ESTELLER
Leader of the Cancer Epigenetics Group 
Bellvitge Biomedical Research Institute (IDIBELL)
Barcelona, Spain

 

   

Prof. John S. MattickJOHN MATTICK
Institute Director and Head, RNA Biology and Plasticity Laboratory
Senior Principal Research Fellow, Garvan Institute of Medical Research
University of New South Wales, Sydney, Australia 

 

  

Dr. Massimo NegriniMASSIMO NEGRINI
Department of Morphology
Surgery and Experimental Medicine
University of Ferrara, Italy

  

Prof. Helge Grosshans
Friedrich Miescher Institute for Biomedical Research (FMI)helge
Basel, Switzerland

 

  

Prof. Menashe Bar-Eli
Department of Cancer Biologybar-eli
The University of Texas MD Anderson Cancer Center, USA

 

 

 

Prof. Qihong HuangHuang
Tumor Microenvironment and Metastasis Program
The Wistar Institute, Philadelphia, USA

 

 


Conference Secretariat

Dr. Franck Vazquez
Dr. Leoni Barrios

Dr. Lucia Russo
Dr. Rui Lui
Ms. Larissa Eisele

Mr. Matthias Burkhalter

E-mail: ncrna-cancer@mdpi.com
Tel. +41 61 683 77 35

Sponsoring Opportunities

For information regarding sponsoring opportunities, please contact the conference secretariat.

Mailing Address

MDPI AG
ISFMS 2017 Secretariat
St. Alban-Anlage 66
4052 Basel, Switzerland
www.mdpi.com

Sponsors